Transcript joint programme of activities

NATIONAL DOCUMENTATION CENTRE
Athens, 18 December 2002
HELLENIC KICK-OFF EVENT
6th Framework Programme
Maria Theofilatou
Framework Programme (2002-2006)
Framework Programme 6 (2002-2006)
Focus on strategic areas where immediate and longer
term integration of European research is needed to
generate and sustain necessary critical mass
New instruments- integrated projects
networks of excellence
Overall architecture of the 6th FP
Focusing and Integrating Community research
« Wider field »
Supporting policies/
Anticipating S/T needs
Citizens
Sustainable dev.
Food
Aeronautics
Nanotechnologies
IST
Genomics
Thematic priorities
SMEs
International co-opération
JRC
Structuring the ERA
Strengthening the foundations of the ERA
Sixth
Framework
Programme
Thematic priorities: € 11285 M
M€
1.1.1 Life sciences, genomics and biotechnology
for health
2255
1.1.2. Information society technologies
3625
1.1.3. Nanotechnologies and nano-sciences, knowledgebased multifunctional materials & processes
1300
1.1.4. Aeronautics and space
1075
1.1.5. Food quality and safety
685
1.1.6. Sustainable development, global change
and ecosystems
1.1.7. Citizens and governance in a
knowledge-based society
2120
225
Thematic priority 1:
Life sciences, genomics and
biotechnology for health
1.1 Advanced genomics and its application
for health
(€ 1100 M)
1.1.a Fundamental knowledge and basic tools for
functional genomics in all organisms
1.1.b Applications of knowledge and technologies in the
field of genomics and biotechnology for health
1.2 Combating major diseases
1.2.a Application oriented genomic approaches to
medical knowledge and technologies
1.2.b Combating cancer
1.2.c Confronting the major communicable
diseases linked to poverty
(€ 1155 M)
755 M
400 M
Thematic priority 1:
Life sciences, genomics and
biotechnology for health
Advanced genomics and its application
for health
(1100 M € )
Fundamental
Genomics
Biotechnology
1.1.a. Fundamental
knowledge and basic
tools for functional
genomics in all organisms
Gene expression and proteomics
Structural genomics
Comparative genomics and population genetics
110001ATC1010
01010101001101
1AUG011010100
10101101010101
010TTC1101010
01001000CCG
Bioinformatics
Multidisciplinary functional genomics approaches
to basic biological processes
Thematic priority 1:
Life sciences, genomics and
biotechnology for health
Combating major diseases
(1155 M € )
Medical
knowledge &
technologies
Cancer
Povertyrelated
diseases
Success will depend on
mobilisation of all actors
SMEs
Academia
Ethical Bodies
Clinicians
DELIVERABLES
Regions
RESEARCH DEVELOPMENT REGULATION
FOR SOCIETY
Private Sector
European
Investment Bank
Member States
Civil Society
Commission
Parliament
From 2000 EoI to
one Workprogramme
• Where do the topics in our
workprogramme come from?
• Submitted EoIs
• Gaps identified by experts
• Commission’s Strategy to foster ERA
• None of the topics reproduce exactly
one EoI:
• Combination of several EoIs
• Addition of elements
• Modification of scope
A balance between
Focusing  Ensuring Competition
Invitation for
Expressions of Interest
An opportunity for Europe’s
research community to help
prepare for the first calls of FP6
• Consultation to the scientific community on its readiness to
implement new instruments in the 7 priority themes of 6FP
• The results have helped to define the Work Programmes and
to prepare the 6FP calls
• It has facilitated the understanding by the research
community of the potential of the new instruments
Expressions of Interest
Result
Whole FP6:
 Some 13.000 EoIs received and
evaluated
Priority one:
 Close to 2.000 EoIs received
 Evaluated with the help of over 200
external experts
 2/3 Integrated Projects and 1/3
Networks
Expressions of Interest
Results
Priority one
IP
NoE
Not
specified
Total
Fundamental genomics
288
190
45
523
Genomics and applied
biotechnology
240
125
36
401
Medical genomics
459
219
24
702
Cancer
196
102
4
302
41
28
1224
664
Poverty related diseases
Total
69
109
Close to
2000 EoI !!!
1997
Priority One
Implementation
53 topics published in the first call
Total budget for first call: EUR 513 million,
broken down as follows:
Instrument
EUR (millions)
Integrated project or network of excellence 385 – 410
Specific targeted research project or
co-ordination action
Specific support actions
92 – 121
8 – 10
Priority One
Implementation
15% of FP budget is for
participation of small and
medium sized enterprises
(SMEs)
Priority One
Implementation
• Ethics:
• Research with human beings
• Research with animals
• Stem cells
• Biological materials or data atribuable to
individuals
• Clinical Trials
• EDCTP
• Pediatrics
New in FP6
Evaluation process
• Call for proposals
• Evaluation by a strengthened peer-review system
– involving individual reviews, remote evaluation, panel sessions,
hearings of applicants…
• Specific criteria will include:
– scientific quality
– potential impact on strengthening Europe’s excellence
– excellence of the network members
– extent, depth and lasting nature of the integration
– contribution to spreading excellence
– management and governance of the network
Thematic priority 1:
Life sciences, genomics and
biotechnology for health
How to find partners?
Former EU-funded projects including
partner information can be found on:
www.cordis.lu/life/src/projects.htm
FP6 Partners Database:
www.cordis.lu/fp6/partners.htm
EoI: eoi.cordis.lu/search_form.cfm
More information
Help-Desk
Life Sciences, Genomics &
Biotechnology for Health:
[email protected]
Instruments for
implementing the
thematic priorities (I)
• Wider range
• Better differentiation
New instruments
– Integrated projects (IP)
– Networks of excellence (NoE)
– Article 169 (joint implementation
national programmes)
of
Instruments for
implementing the
thematic priorities (II)
Traditional instruments
– Specific targeted research projects
– Co-ordination actions
– Specific support actions
Principles guiding their
design (I)
• Simplification and streamlining
– to minimise the overheads for all concerned
whether applicant, contractor or the Commission
– to speed up procedures, especially time-tocontract
• Flexibility and adaptability
– to enable instruments to be applicable
throughout the priority themes
– to enable projects to evolve
Principles guiding
their design (II)
• Increased management autonomy
– to eliminate unnecessary micro-management
• While preserving public accountability and
protecting interests of the Community
Classification of the
instruments
Instrument
Purpose
Primary
deliverable
Scale
IP
objectivedriven research
knowledge
med-high
NoE
tackle
fragmentation
structuring
med-high
Art. 169
joint MS
programmes
knowledge and/or
structuring
high
STREP
research
knowledge
low-med
CA
coordination
coordination
low-med
SSA
support
support
low-med
Instruments to be used
in priority (I)
• Calls for proposals will identify which
instruments are to be used, which have priority,
and for what
• From the outset, IPs and NoE will be the priority
means
– for implementing those themes where it is
already deemed appropriate
– while maintaining the use of specific targeted
research projects and coordination actions
Instruments to be used
in priority (II)
• In 2004, the Commission will arrange an
independent evaluation of the use of the
instruments
– may lead to an adjustment of their relative
weightings
“FP6
Integrated
Projects”
Purpose of Integrated
Projects (I)
• Designed to generate the knowledge required to implement
the priority thematic areas of FP6
– by integrating the critical mass of activities and
resources needed
– to achieve ambitious, clearly defined scientific and
technological objectives
• Essentially an instrument for supporting objective-driven
research of a European dimension
Activities
Activities integrated by a project may cover the full research
spectrum
– should contain objective-driven research
– technological development and demonstration components
as appropriate
– may contain a training component
– the effective management of knowledge will also be an
essential feature
– the whole carried out in a coherent management
framework
Rates of Community
support
• Maximum rates of support for FC and FCF participants:
– 50% for RTD and innovation-related components
– 35% for any demonstration component
– 100% for any training activities
– 100% for consortium management
• AC participants: supported at up to 100% for all
components of the project (except for consortium
management which will be supported as under FCF)
• For IPs, no more than 7% of the Community contribution
can be used to support consortium management costs
reimbursed at up to 100%
What is the scale of
critical mass (I)?
• Concerning resources: each IP must assemble the
critical mass of resources needed to achieve its
ambitious objectives
– activities integrated may range up to several
tens of million euro
– but no minimum threshold, provided necessary
ambition and critical mass is achieved
What is the scale of
critical mass (II)?
• Concerning the partnership: minimum of 3 participants
from 3 different Member States or Associated States, of
which at least 2 should be Member States or Associated
candidate countries
– but in practice likely to be substantially more
– SME participation is strongly encouraged
– ‘third country’ participants may be included, with a
possibility of Community financial support for entities
from certain groups of countries
What is the scale of
critical mass (III)?
• Concerning its duration: typically 3 to 5 years
– but more if necessary to deliver the
objectives
Proposal
submission (I)
• Through calls for proposals
– may be preceded by expressions of interest to help
focus calls and assist in consortium building
• Simplified proposal-making
– requiring only sufficient “management-level” detail
– reflecting evolutionary nature of the project
• summary description of activities for entire
duration
• detailed implementation plan only for first 18
months
Flexibility and autonomy
of implementation (II)
• For changes in the consortium
– the consortium may itself decide to take in new
participants (though without additional funding)
• the contract will specify when this must
involve a competitive call
– the Commission may decide to launch calls to add
activities and participants (with additional funding)
• e.g. to enhance SME participation
Monitoring
• Robust monitoring of each IP by the Commission
– by one or possibly a team of project officers
– through
• annual review
• mid-term or milestone review (optional)
• final review
– involving external experts at all stages
More Information on the
instruments
• Regularly updated website on the instruments
– europa.eu.int/comm/research/fp6/networks-ip.html
• Brochures and leaflets on the new instruments (also
available on Europa as above)
• Presentation slides (on Europa as above)
• Guide on “Participating in European Research”
• On integrated projects
• [email protected]
“FP6
Networks
of
excellence”
europa.eu.int/comm/research/nfp/networks-ip.html
NoE Objectives
Strengthen Europe’s excellence on a particular research
topic
by integrating the critical mass of expertise needed to
provide European leadership and be a world force
around a joint programme of activities
Tackling the fragmentation of European research
where the main deliverable is a durable structuring and
shaping of how research is carried out in Europe
Spreading excellence beyond its partners
NoE
The joint programme
of activities (1)
A range of new or re-oriented activities:
Integrating activities
•coordinated programming of the partners’ activities
•sharing of research platforms/tools/facilities
•joint management of the knowledge portfolio
•staff mobility and exchanges
•relocation of staff, teams, equipment
•reinforced electronic communication systems
NoE
The joint programme
of activities (2)
Joint research activities: a programme of joint
research to support the network’s goals
•development of new research tools and platforms
for common use
•generating new knowledge to fill gaps in or to
extend the collective knowledge portfolio
NoE
The joint programme
of activities (3)
Activities to spread excellence
•training researchers and other key staff
•dissemination and communication activities
•networking activities to help transfer knowledge to
trams external to the network
•where appropriate, promoting the exploitation of
the results generated within the network
•where appropriate, innovation-related activities
NoE
The joint programme
of activities (4)
Network management
•overall coordination of the joint activities
•communication with the Commission, reporting
•activities linked to consortium-level financing and
accounting management and legal issues
•coordination of the knowledge management activities, if
appropriate, other innovation-related activities
•promotion of gender equality
•science and society issues
•supporting the governing board and other network
bodies
ALL ACTIVITIES WITHIN
A COHERENT MANAGEMENT FRAMEWORK
NoE
Measuring integration(1)
In their proposal, participants will
include possible qualitative and
quantitative indicators for measuring
progress towards integration
NoE
Measuring integration(2)
Main factors to be examined
•extent of mutual specialisation and mutual
complementarity
•sharing /development for common use of
research infrastructure, equipment, tools and
platforms
•regular joint execution of research projects
NoE
Measuring integration(3)
Main factors to be examined
•interactive working through electronic
communication systems
•joint management of the knowledge
portfolio
•joint training programme (researchers
and other key staff)
•coherent management framework
NoE
Critical mass (1)
Expertise: assembling of the
critical mass needed to achieve the
ambitious goals of the network
variable from topic to topic
larger networks may involve several
hundreds of researchers
may be smaller provided that the
necessary ambition and critical mass
are achieved
NoE
Critical mass (2)
Partnership: in general at least six (legal
minimum: 3 from 3 different countries)
Duration of Community support:typically
5 years
more if necessary BUT no more than 7
years
NoE
Financial regime (1)
Community support targeted at overcoming the
barriers to a durable integration
•these barriers are mainly organisational, cultural,
human  cannot be quantified in normal accounting
terms
Has led to the concept of an incentive, taking the
form of a global “fixed grant for integration”
NoE
Financial regime(2)
A fixed grant for integration, acting as an incentive,
calculated on basis:
•of the degree of integration
•of the total number of researchers
•of the characteristics of the field of research
•of the joint programme of activities
•with a bonus for registered doctoral students
NoE
Financial regime(3)
The average annual grant to a network could vary with the
number of researchers as follows:
50 researchers
100 researchers
150 researchers
250 researchers
500 researchers
1000 researchers and above
€ 1 million/year
€ 2 million/year
€ 3 million/year
€ 4 million/year
€ 5 million/year
€ 6 million/year
(for intermediate numbers, the grant would be calculated
by linear interpolation)
A network of 200 researchers supported over 5 years
would therefore receive a fixed grant of € 17,5 million
(plus bonus for registered doctoral students)
Reminder
Main NoE features(1)
Demonstrated need for structuring
•description of fragmentation on the topic
•existence of excellent capacities in Europe
in the topic
 Is there a real need for a structuring
intervention?
Reminder
Main NoE features(2)
Characteristics of the network planned:
•composition of the partnership: presence of key
excellent actors
•potential synergies, complementarities,
specialisation among the members
•quality/degree of integration planned
 Is the network planned likely to tackle
the fragmentation problem identified?
Reminder
Main NoE features(3)
Viability of the network during and beyond
the period
•awareness of high decision level representatives
of the participating organisations: strong
commitment
•security regarding network’s funding, particularly
beyond the period
 Will the network constitute a durable
answer to the problem identified?
More information?
Regularly updated website on the instruments:
europa.eu.int/comm/research/fp6/networksip.html
Brochures and leaflets on the new instruments:
available at Heysel conference and on Europa as
above
Presentation slides: on Europa as above
Networks of excellence: [email protected]